设为首页 电子邮箱 联系我们

本刊最新招聘信息请见“通知公告”!  本刊投稿系统试运行中,欢迎投稿!如投稿有问题,可直接将稿件发送至zgyy8888@163.com

 

主管单位:中华人民共和国   

国家卫生健康委员会

主办单位:中国医师协会
总编辑:
杨秋

编辑部主任:吴翔宇

邮发代号:80-528
定价:28.00元
全年:336.00元
Email:zgyy8888@163.com
电话(传真):010-64428528;
010-64456116(总编室)

                  

过刊目录

2022 年第 4 期 第 17 卷

全血硒水平与妊娠晚期甲状腺功能减退的关系及对妊娠结局的影响

The relationship between the level of whole blood selenium and hypothyroidism in the third trimester and its influence on pregnancy outcome

作者:张小菜1徐珊1王敏1朱丽红1袁宁霞1薛静2裴巧丽1

英文作者:Zhang Xiaocai1 Xu Shan1 Wang Min1 Zhu Lihong1 Yuan Ningxia1 Xue Jing2 Pei Qiaoli1

单位:1陕西中医药大学第二附属医院产科,咸阳712000;2陕西中医药大学第二附属医院检验科,咸阳712000

英文单位:1Department of Obstetrics the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine Xianyang 712000 China; 2Department of Clinical Laboratory the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine Xianyang 712000 China

关键词:甲状腺功能减退;妊娠晚期;全血硒水平;妊娠结局

英文关键词:Hypothyroidism;Thirdtrimester;Levelofwholebloodselenium;Pregnancyoutcome

  • 摘要:
  • 目的 探讨全血硒水平与妊娠晚期甲状腺功能减退(甲减)的关系及对妊娠结局的影响。方法 选取20191月至20209月于陕西中医药大学第二附属医院接受孕期检查的414例妊娠晚期女性。根据甲状腺功能检测结果,将414例孕妇分为甲减组(包括临床甲减及亚临床甲减,33例)和正常组(甲状腺功能正常,381例)。分析孕妇的全血硒水平及甲减发生率。比较甲减组与正常组孕妇的临床资料,采用多因素Logistic回归方法分析妊娠晚期孕妇发生甲减的危险因素。根据全血硒水平中位值将414例孕妇分为全血硒低水平组(全血硒水平<98.28 μg/L207例)与全血硒高水平组(全血硒水平≥98.28 μg/L207例),比较2组妊娠结局。结果 414例妊娠晚期孕妇的全血硒水平为(98±14)μg/L。正常组孕妇的全血硒水平明显高于甲减组孕妇[(98±13)μg/L比(93±13)μg/L](P=0.041)。全血硒低水平组的亚临床甲减发生率与甲减总发生率均高于全血硒高水平组[9.7%20/207)比3.4%7/207)、12.1%25/207)比3.9%8/207)](均P0.05)。多因素Logistic回归分析结果显示,年龄≥35岁、经产、孕前体重指数<18 kg/m2、维生素D缺乏、全血硒低水平是妊娠晚期甲减的危险因素(均P0.05)。全血硒低水平组的胎膜早破、流产、胎儿窘迫发生率均高于全血硒高水平组(均P0.05)。结论 年龄≥35岁、经产、孕前体重指数<18 kg/m2、维生素D缺乏、全血硒低水平是妊娠晚期甲减的危险因素,全血硒水平偏低孕妇更容易出现不良妊娠结局。


  • Objective To explore the relationship between the level of selenium (Se) in whole blood and hypothyroidism in the third trimester and its influence on pregnancy outcome. Methods Totally 414 women in the third trimester who underwent prenatal examination in the Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine from January 2019 to September 2020 were selected. According to the results of thyroid function test, the pregnant women were divided into hypothyroidism group (including clinical hypothyroidism and subclinical hypothyroidism, 33 cases) and normal group (normal thyroid function, 381 cases). The level of whole blood Se and the incidence of hypothyroidism were analyzed. The clinical data were compared between the two groups, and the risk factors of hypothyroidism in the third trimester were analyzed by multivariate Logistic regression analysis. All the pregnant women were divided into whole blood Se low level group (whole blood Se level98.28 μg/L, 207 cases) and whole blood Se high level group (whole blood Se level98.28 μg/L, 207 cases) according to the median level of whole blood Se, and the pregnancy outcome of the two groups were compared. Results The level of Se in whole blood of 414 pregnant women in the third trimester was (98±14)μg/L. The level of whole blood Se in normal group was significantly higher than that in hypothyroidism group(98±13)μg/L vs (93±13)μg/L(P=0.041). The incidence of subclinical hypothyroidism and the total incidence of hypothyroidism in whole blood Se low level group were higher than those in whole blood Se high level group9.7%(20/207) vs 3.4%(7/207), 12.1%(25/207) vs 3.9%(8/207)(both P0.05). Multivariate Logistic regression analysis showed that age 35 years, multipara, pre-pregnancy body mass index(BMI)18 kg/m2, vitamin D deficiency and low level of whole blood Se were the risk factors of hypothyroidism in the third trimester (all P0.05). The incidences of premature rupture of membranes, abortion and fetal distress in whole blood Se low level group were higher than those in whole blood Se high level group (all P0.05). Conclusions Age35 years, multipara, pre-pregnancy BMI18 kg/m2, vitamin D deficiency, and low level of whole blood Se are risk factors for hypothyroidism in the third trimester. Pregnant women with low level of whole blood Se are more likely to have adverse pregnancy outcome.

copyright 《中国医药》杂志编辑部
地址:北京市朝阳区安贞路2号首都医科大学附属北京安贞医院北楼二层
电话:010-64456116 传真:010-64428528 邮编:100029 Email: zgyy8888@163.com
网址:www.chinamedicinej.com 京ICP备2020043099号-3

当您在使用本网站投稿遇到困难时,请直接将稿件投送到编辑部邮箱zgyy8888@163.com。







安卓


苹果

关闭